Tetsutaro Hayashi
Overview
Explore the profile of Tetsutaro Hayashi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
174
Citations
2711
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kobatake K, Goto K, Sakamoto Y, Iwane K, Nishida K, Hashimoto K, et al.
Int J Urol
. 2025 Feb;
PMID: 39930593
Objective: This study evaluated whether first-line treatment affects survival outcomes in patients with advanced urothelial carcinoma undergoing sequential therapy with chemotherapy, immune checkpoint inhibitors, and enfortumab vedotin. Methods: This multicenter...
2.
Kobayashi G, Sekino Y, Nakahara H, Kobatake K, Goto K, Hayashi T, et al.
J Cancer Res Clin Oncol
. 2024 Dec;
151(1):18.
PMID: 39739128
Background: Urothelial carcinoma (UC) is a common type of malignant disease; however, the diagnostic and prognostic markers of upper urinary tract urothelial cancer (UTUC) remain poorly understood because of its...
3.
Takase H, Mishina T, Hayashi T, Yoshimura M, Kuse M, Nikaido I, et al.
PLoS One
. 2024 Oct;
19(10):e0311978.
PMID: 39441825
Primordial follicle activation (PFA) is a pivotal event in female reproductive biology, coordinating the transition from quiescent to growing follicles. This study employed comprehensive single-cell RNA sequencing to gain insights...
4.
Kobatake K, Ikeda K, Kohada Y, Tasaka R, Takemoto K, Fukushima T, et al.
Anticancer Res
. 2024 Apr;
44(5):1947-1954.
PMID: 38677755
Background/aim: Recent studies have reported conflicting findings regarding the significance of hydronephrosis (HN) in muscle-invasive bladder cancer (MIBC). The molecular characteristics of MIBC with HN are unclear, therefore, we aimed...
5.
Miyamoto S, Goto K, Tasaka R, Kohada Y, Fukushima T, Takemoto K, et al.
Sci Rep
. 2024 Feb;
14(1):4780.
PMID: 38413713
To propose the centrality angle (C-angle) as a novel simple nephrometry score for the evaluation of tumor complexity and prediction of perioperative outcomes in nephron-sparing surgery (NSS) for renal tumors....
6.
Hayashi T, Kitano H, Hieda K, Hinata N
Transl Cancer Res
. 2024 Feb;
13(1):471-479.
PMID: 38410228
Background: The field of robotic surgery is still continuously advancing, with several cutting-edge robotic systems currently under development. This study aimed to present the methodology and perioperative outcomes of robot-assisted...
7.
Kohada Y, Goto K, Tasaka R, Nishida K, Hashimoto K, Iwamoto H, et al.
Clin Genitourin Cancer
. 2023 Dec;
22(2):322-329.e3.
PMID: 38104030
Introduction: The modified 5-item frailty index can be used to evaluate frailty using 5 routinely encountered clinical variables. This study aimed to assess the impact of the modified 5-item frailty...
8.
Nishiyama N, Kita Y, Ito K, Kato M, Hatakeyama S, Matsushita Y, et al.
Anticancer Res
. 2023 Nov;
43(11):5041-5050.
PMID: 37909969
Background/aim: To evaluate the difference in the clinical efficacy and safety of pembrolizumab between patients with metastatic upper tract urothelial carcinoma (UTUC), which includes renal pelvic urothelial carcinoma (UC) and...
9.
Fukushima T, Goto K, Hayashi T, Ikeda K, Hatayama T, Yamanaka R, et al.
Jpn J Clin Oncol
. 2023 Oct;
54(2):175-181.
PMID: 37899139
Objective: Comprehensive genomic profiling testing using a hybrid-capture next-generation sequencing is commonly used in clinical practice to employ precision medicine in cancer treatment worldwide. In this study, we aimed to...
10.
Takada H, Sasagawa Y, Yoshimura M, Tanaka K, Iwayama Y, Hayashi T, et al.
Nat Commun
. 2023 Oct;
14(1):6540.
PMID: 37848419
No abstract available.